Search Count: 18
 |
Egfr (L858R, T790M, V948R) In Complex With N-{3-[(2-{[4-(4-Methylpiperazin-1-Yl)Phenyl]Amino}-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Oxy]Phenyl}Prop-2-Enamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.52 Å Release Date: 2016-02-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 633, SO4, GOL |
 |
Egfr (L858R, T790M, V948R) In Complex With N-[3-({2-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl}Oxy)Phenyl]Prop-2-Enamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2016-02-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 634, SO4, GOL |
 |
Egfr (L858R, T790M, V948R) In Complex With 1-[(3R,4R)-3-[({2-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl}Oxy)Methyl]-4-(Trifluoromethyl)Pyrrolidin-1-Yl]Prop-2-En-1-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2016-02-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 63A, SO4, GOL |
 |
Egfr (L858R, T790M, V948R) In Complex With 1-{(3R,4R)-3-[5-Chloro-2-(1-Methyl-1H-Pyrazol-4-Ylamino)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yloxymethyl]-4-Methoxy-Pyrrolidin-1-Yl}Propenone (Pf-06459988)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2016-01-27 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 630, SO4 |
 |
Catalytic Unit Of Pi3Kg In Complex With Pi3K/Mtor Dual Inhibitor Pf-04979064
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2013-11-20 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 19P |
 |
Discovery Of A Novel, Potent And Selective Inhibitor Of 3-Phosphoinositide Dependent Kinase (Pdk1)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2011-11-16 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: GOL, SO4, ABQ |
 |
Discovery Of A Novel, Potent And Selective Inhibitor Of 3-Phosphoinositide Dependent Kinase (Pdk1)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2011-11-16 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 3RW, GOL, SO4 |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: WOE |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU5 |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU3 |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU7, PO4 |
 |
Discovery Of The Highly Potent Pi3K/Mtor Dual Inhibitor Pf-04691502 Through Structure Based Drug Design
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2010-06-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: ML8 |
 |
Discovery Of The Highly Potent Pi3K/Mtor Dual Inhibitor Pf-04691502 Through Structure Based Drug Design
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2010-06-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: ML9 |
 |
Hsp90 N-Terminal Domain In Complex With 4-Chloro-6-{[(2R)-2-(2-Methylphenyl)Pyrrolidin-1-Yl]Carbonyl}Benzene-1,3-Diol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2010-02-09 Classification: CHAPERONE Ligands: 4CD, DMS |
 |
Hsp90 N-Terminal Domain In Complex With (1R)-2-(5-Chloro-2,4-Dihydroxybenzoyl)-N-Ethylisoindoline-1-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2010-02-09 Classification: CHAPERONE Ligands: 1RC, PO4 |
 |
Hsp90 N-Terminal Domain In Complex With 4-(1,3-Dihydro-2H-Isoindol-2-Ylcarbonyl)Benzene-1,3-Diol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2010-02-09 Classification: CHAPERONE Ligands: PFT |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2008-11-25 Classification: CHAPERONE Ligands: PYU, PO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2008-11-25 Classification: CHAPERONE Ligands: PY9, PO4 |